Halasz
Edmund Halasz, Orbe CH
Patent application number | Description | Published |
---|---|---|
20130148118 | SPARK CHAMBER FOR OPTICAL EMISSION ANALYSIS - A spark chamber for an optical emission analyser, comprising: a gas inlet located on a first side of the spark chamber for supplying a gas into the spark chamber; and a gas outlet located on a second side of the spark chamber arranged to convey the gas from the spark chamber; wherein an elongated electrode having an electrode axis generally along the direction of elongation is located within the spark chamber; and wherein: the first and second sides of the spark chamber lie at either side of the elongated electrode in directions generally perpendicular to the electrode axis; there is a gas flow axis through the spark chamber between the gas inlet and the gas outlet; and on passing along the gas flow axis from the gas inlet to the gas outlet the unobstructed internal cross sectional area of the spark chamber perpendicular to the gas flow axis remains constant to within a factor A, wherein A lies between 1.0 and 2.0. | 06-13-2013 |
Maria Halasz, Sydney AU
Patent application number | Description | Published |
---|---|---|
20130067604 | Method of Treatment or Prevention of Hair Loss or for the Enhancement of Hair Growth - The present application relates to use of a Midkine family protein for growing hair on a mammal, or in the manufacture of a medicament for growing hair on a mammal, especially for treatment or prevention of different forms of alopecia. | 03-14-2013 |
20140170144 | ANTIBODY RECOGNIZING N-DOMAIN OF MIDKINE - The present disclosure relates to isolated or recombinant proteins, such as antibodies, which inhibit or reduce the function of midkine (hereinafter, referred to as “MK”) for use in the treatment or prevention of midkine-related disorders. | 06-19-2014 |
20150044139 | Method of Treatment or Prevention of Hair Loss or for the Enhancement of Hair Growth - The present application relates to use of a Midkine family protein for growing hair on a mammal, or in the manufacture of a medicament for growing hair on a mammal, especially for treatment or prevention of different forms of alopecia. | 02-12-2015 |
Robert Halasz, Nacka SE
Patent application number | Description | Published |
---|---|---|
20100298810 | PHARMACEUTICAL COMPOSITION AND NASAL RINSING DEVICE THEREFOR - Vaccine is administered into a nose. A pharmaceutically-acceptable aqueous saline solution carrier comprising from 0.5% to 1.9% salt is provided in a nasal device. The saline solution is administered into a first nasal cavity to rinse the first nasal cavity. The saline solution is added to the first nasal cavity until the saline solution flows via a posterior nasal aperture into a second nasal cavity. A vaccine is then administered into the first nasal cavity. | 11-25-2010 |